Vericel Corp: Form 10-Q for the period ended Sep 30, 2012
Filed with the SEC on Nov 8, 2012 and accepted by EDGAR at Nov 8, 2012, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 9 months2012-01-01 to 2012-09-30 | $2.0k | us-gaap:SalesRevenueNet |
| Cost of revenue | 9 months2012-01-01 to 2012-09-30 | $2.0k | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2012-07-01 to 2012-09-30 | $6.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2012-01-01 to 2012-09-30 | $20.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-07-01 to 2012-09-30 | $2.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2012-01-01 to 2012-09-30 | $6.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-07-01 to 2012-09-30 | −$8.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-01-01 to 2012-09-30 | −$26.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-07-01 to 2012-09-30 | $4.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2012-01-01 to 2012-09-30 | $10.0k | us-gaap:InterestExpense |
| Net income | 3 months2012-07-01 to 2012-09-30 | −$6.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-01-01 to 2012-09-30 | −$22.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-07-01 to 2012-09-30 | −$0.17 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2012-01-01 to 2012-09-30 | −$0.63 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2012-01-01 to 2012-09-30 | −$22.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2012-01-01 to 2012-09-30 | $169.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-09-30 | $21.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-09-30 | $21.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-09-30 | $22.7m | us-gaap:Assets |
| Current liabilities | At period end2012-09-30 | $7.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-09-30 | $7.0m | us-gaap:Liabilities |
| Long-term debt | At period end2012-09-30 | $9.0k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-09-30 | $40.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-09-30 | −$24.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-12-075979. Last ingested by Listed: Nov 14, 2026, 12:33 ET. Listed shows no prices and gives no investment advice.